Drug Information Association Logo

Study Endpoints

Already a Member? Visit this Community           Not a Community Member? Join

Chairperson. Chad Gwaltney, ERT and Annabel Nixon, PRMA Consulting Ltd


To advance the scientific development and evaluation of study endpoints and the assessments that underlie them, including:

  • Patient reported outcomes (PROs)
  • Clinician reported outcomes (ClinROs)
  • Observer reported outcomes (ObsROs)
  • Performance outcomes (PerfOs)
  • Biomarkers;

To facilitate discussion about study endpoints among all medical product development stakeholders;
To educate professionals in the biopharmaceutical and healthcare industries about scientific approaches to the development and evaluation of study endpoints; and
To publish best practice documents that can be used by a variety of stakeholders to develop and evaluate study endpoints.

Take advantage of all the benefits of membership.

Become a DIA Member


Media PlayerInstant Download! Beyond Taxonomy  

This audiosynchronized presentation explores the taxonomy of study endpoints and its importance to study design.

Media PlayerDownload presentation. 

Manage My Community Memberships